AI Interventions in Climate Change: A Potential Solution for the NHS and Beyond

By Sumona Bose

December 23, 2023

Introduction

Artificial intelligence (AI) is reconfiguring various industries, and its potential impact on healthcare and climate change is gaining attention. The English National Health Service (NHS) aims to provide more efficient care while reducing its climate impact. However, concerns about carbon emissions from AI models have emerged. This article explores the role of AI in climate change debates and emission detection, with a focus on its implications for the NHS and beyond. It will also demonstrate how AI interventions in climate change can account for a potential solution for the NHS and beyond.

AI in Healthcare and Climate Improvement

AI tools have the potential to improve the quality and efficiency of healthcare services, including climate improvement and energy efficiency. However, the lack of standardized reporting for power, energy, and efficiency metrics in the field of AI poses challenges for direct comparison and implementation. To address this, future studies should design approaches for standard climate reporting that can be used by the NHS and AI developers.

 


Figure 1: How is the NHS using AI for clinical use cases? We take a patient, provider, process, and public health approach to reviewing the implementation of AI tools. Deployed tools are either being routinely used in clinical practice or are in clinical pilots. Near tools are in a research environment and being applied to clinical problems. Future tools are yet to be applied to clinical settings and require validation.

 

UK’s Net Zero Strategy

As the host of the United Nations Climate Change Conference (COP26) in 2021, the UK has an opportunity to showcase the progress of the NHS towards achieving net zero emissions by 2040. AI is expected to play a major role in future healthcare delivery, including managing the efficiency of health system operations. For example, AI can optimize building management and reduce energy consumption.

Exploring AI’s Climate Impact

While the literature on AI models, computational power, and processing times is extensive, there is a lack of focus on the climate impact of AI in clinical settings. Further exploration is needed to understand the efficiency of AI models and how they can be used to reduce carbon emissions in healthcare.

Considering the Social Care Sector

The social care sector, which is developing new technologies such as fall detection algorithms, has the advantage of considering sustainability and carbon impact from inception to implementation. Lessons from this sector can be applied to healthcare to reduce climate impact.

The Need for Further Research and Action

To better understand the climate impact of AI development and weigh the cost-benefit of implementing AI technologies, more research is needed. The NHS should support the development of AI tools by implementing standardized climate reporting and exploring opportunities for reducing model size and improving efficiency. The impact of AI tools themselves should be established, reduced, and offset as part of overall reduction and offsetting targets.

As AI technologies continue to advance in healthcare, it is crucial to consider their climate impact and address it throughout their life cycle.

Reference url

Recent Posts

Novartis patent cliff layoffs
     

Engineering Resilience: Mastering Pharma Patent Expiration Strategy

🚨 Are you still reacting to pharmaceutical patent expirations with layoffs and litigation, or are you ready to engineer a strategy that turns the patent cliff into your next competitive edge?

Patent expirations don’t have to derail your pharma portfolio. Learn how to outmaneuver generics and transform challenges into advantages. Dive into our latest insights and take control today.

#SyenzaNews #pharmaceuticals #innovation #PharmaStrategy #patentcliffs

diabetes medicine access
               

Improving Diabetes Medicine Access: Key Changes in the Pharmaceutical Benefits Scheme

🚀 Are we on the verge of a breakthrough in diabetes medication accessibility?

The latest updates to the Pharmaceutical Benefits Scheme (PBS) are set to transform type 2 diabetes management by expanding access to essential medicines like empagliflozin and streamlining the prescribing process for glucagon-like peptide 1 receptor agonists (GLP-1 RAs). These changes not only prioritize equity for high-risk populations but also align with global trends in cost-effective healthcare.

Dive deeper into how these revisions could reshape diabetes care and promote better health outcomes for all.

#SyenzaNews #HealthcareInnovation #healthcare #MarketAccess

HPV testing HNSCC
    

HPV Testing in Head and Neck Squamous Cell Carcinoma

🔍 Are you up-to-date with the latest advancements in HPV testing for head and neck cancer?

Our comprehensive article looks into the innovation of diagnostic methods for HPV status determination in head and neck squamous cell carcinoma (HNSCC). From traditional p16 immunohistochemistry to innovative liquid biopsies, discover the critical role these advancements play in prognosis, treatment planning, and improving patient outcomes.

Look into this essential topic and see how these insights could revolutionize clinical practices.

#SyenzaNews #oncology #HealthTech #HealthcareInnovation

When you partner with Syenza, it’s like a Nuclear Fusion.

Our expertise are combined with yours, and we contribute clinical expertise and advanced degrees in health policy, health economics, systems analysis, public finance, business, and project management. You’ll also feel our high-impact global and local perspectives with cultural intelligence.

SPEAK WITH US

CORRESPONDENCE ADDRESS

1950 W. Corporate Way, Suite 95478
Anaheim, CA 92801, USA

© 2025 Syenza™. All rights reserved.